Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis

Evans, 1985, The quality of life of patients with end-stage renal disease, N Engl J Med, 312, 553, 10.1056/NEJM198502283120905 Valderrabano, 2001, Quality of life in end-stage renal disease patients, Am J Kidney Dis, 38, 443, 10.1053/ajkd.2001.26824 2001, 490 Ries, 1994 Jofre, 1998, Changes in quality of life after renal transplantation, Am J Kidney Dis, 32, 93, 10.1053/ajkd.1998.v32.pm9669429 Cameron, 2000, Differences in quality of life across renal replacement therapies, Am J Kidney Dis, 35, 629, 10.1016/S0272-6386(00)70009-6 Wolfe, 1999, Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med, 341, 1725, 10.1056/NEJM199912023412303 Owen, 1993, The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis, N Engl J Med, 329, 1001, 10.1056/NEJM199309303291404 Held, 1996, The dose of hemodialysis and patient mortality, Kidney Int, 50, 550, 10.1038/ki.1996.348 Port, 2002, Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients, J Am Soc Nephrol, 13, 1061, 10.1681/ASN.V1341061 Eknoyan, 2002, Effects of dialysis dose and membrane flux in maintenance hemodialysis, N Engl J Med, 347, 2010, 10.1056/NEJMoa021583 Mitka, 2002, How to reduce mortality in hemodialysis patients still a puzzle, JAMA, 287, 2643, 10.1001/jama.287.20.2643-JMN0522-3-1 Buoncristiani, 1998, Fifteen years of clinical experience with daily haemodialysis, Nephrol Dial Transplant, 13, 148, 10.1093/ndt/13.suppl_6.148 Pierratos, 1998, Nocturnal hemodialysis, J Am Soc Nephrol, 9, 859, 10.1681/ASN.V95859 Mastrangelo, 1998, Dialysis with increased frequency of sessions (Lecce dialysis), Nephrol Dial Transplant, 13, 139, 10.1093/ndt/13.suppl_6.139 Ting, 1998, Short daily hemodialysis—Clinical outcomes and quality of life, J Am Soc Nephrol, 9, 228A Woods, 1999, Clinical and biochemical correlates of starting “daily” hemodialysis, Kidney Int, 55, 2467, 10.1046/j.1523-1755.1999.00493.x Kooistra, 1998, Daily home haemodialysis in The Netherlands, Nephrol Dial Transplant, 13, 2853, 10.1093/ndt/13.11.2853 Lockridge, 1999, Nightly home hemodialysis, Home Hemodialysis Int, 3, 23, 10.1111/hdi.1999.3.1.23 Galland, 2001, Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients, Kidney Int, 60, 1555, 10.1046/j.1523-1755.2001.00959.x Traeger, 1999, Time needed to improve clinical parameters by daily hemodialysis, Home Hemodialysis Int, 3, 29, 10.1111/hdi.1999.3.1.29 Daugirdas, 1992, Second generation logarithmic estimates of single-pool variable volume Kt/V, J Am Soc Nephrol, 4, 1205, 10.1681/ASN.V451205 Gotch, 1998, The current place of urea kinetic modeling with respect to different dialysis modalities, Nephrol Dial Transplant, 13, 10, 10.1093/ndt/13.suppl_6.10 Tattersall, 1996, The post-dialysis rebound, Kidney Int, 50, 2094, 10.1038/ki.1996.534 Clase, 2001, Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease, Nephrol Dial Transplant, 16, 1925, 10.1093/ndt/16.9.1925 Wolfe, 2002, URR > 75% is associated with lower mortality among females but not among males, J Am Soc Nephrol, 13, 20A Depner, 2002, Does gender influence the effect of dialysis dose on mortality? Results of the HEMO study, J Am Soc Nephrol, 13, 422A Depner, 2003, Prescribing hemodialysis, Adv Ren Replace Ther, 10, 71, 10.1053/jarr.2003.50007 Lowrie, 2000, The urea (clearance × time) product (Kt) as an outcome-based measure of hemodialysis dose, Kidney Int, 56, 738 Owen, 1998, Dose of hemodialysis and survival, JAMA, 280, 1764, 10.1001/jama.280.20.1764 Kjellstrand, 1999, Why daily hemodialysis is better, Semin Dial, 12, 472, 10.1046/j.1525-139x.1999.99073.x Lopot, 1998, Quantification of dialysis unphysiology, Nephrol Dial Transplant, 13, 74, 10.1093/ndt/13.suppl_6.74 Odar-Cederlof, 2001, Plasma levels of brain natriuretic peptide (BNP) and cardiac function in daily dialysis, J Am Soc Nephrol, 12, 404A Zilch, 2001, Daily dialysis reduces peripheral vascular resistance and sympathetic activity, J Am Soc Nephrol, 12, 280A Depner, 1998, Benefits of more frequent dialysis, Nephrol Dial Transplant, 13, 20, 10.1093/ndt/13.suppl_6.20 Depner, 1999, Why daily hemodialysis is better, Semin Dial, 12, 462, 10.1046/j.1525-139X.1999.99071.x Depner, 2001, Daily hemodialysis efficiency, Adv Ren Replace Ther, 8, 227, 10.1053/jarr.2001.27594 Galland, 1999, Daily hemodialysis versus standard hemodialysis, Home Hemodialysis Int, 3, 33, 10.1111/hdi.1999.3.1.33 Casino, 1996, The equivalent renal urea clearance, Nephrol Dial Transplant, 11, 1574, 10.1093/oxfordjournals.ndt.a027616 1997, DOQI Clinical Practice Guidelines for Hemodialysis Adequacy, Am J Kidney Dis, 30, S22 1997, DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy, Am J Kidney Dis, 30, S70 Keshaviah, 1989, The peak concentration hypothesis, Perit Dial Int, 9, 257, 10.1177/089686088900900405 Port, 1993, The study of outcomes for CAPD versus hemodialysis patients, Perit Dial Int, 16, 628, 10.1177/089686089601600614 Charra, 1996, Importance of treatment time and blood pressure control in achieving long-term survival on dialysis, Am J Nephrol, 16, 35, 10.1159/000168968 Sezer, 2000, What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?, Adv Perit Dial, 16, 177 Ifudu, 1996, The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease, N Engl J Med, 334, 420, 10.1056/NEJM199602153340702 Ifudu, 1998, Effect of increased hemodialysis dose on endogenous erythropoietin production in end-stage renal disease, Nephron, 79, 50, 10.1159/000044991 Erslev, 1995, The rate and control of baseline red cell production in hematologically stable patients with uremia, J Lab Clin Med, 126, 283 Eschbach, 1985, Anemia of end stage renal disease (ESRD), Kidney Int, 28, 1, 10.1038/ki.1985.109 McPhatter, 1999, Nightly home hemodialysis, Adv Ren Replace Ther, 6, 358, 10.1016/S1073-4449(99)70048-8 Mucsi, 1998, Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis, Kidney Int, 53, 1399, 10.1046/j.1523-1755.1998.00875.x Lugon, 2001, Effects of in-center daily hemodialysis upon mineral metabolism and bone disease in end-stage renal disease patients, Sao Paolo Med J, 119, 105, 10.1590/S1516-31802001000300004 Chan, 2001, Improvement in phosphate control with short daily in-center hemodialysis, J Am Soc Nephrol, 12, 262A Buoncristiani, 1989, Dramatic improvement of clinical-metabolic parameters and quality of life with daily dialysis, Int J Artif Organs, 12, 133 Manns, 2002, Dialysis adequacy and health related quality of life in hemodialysis patients, ASAIO J, 48, 565, 10.1097/00002480-200209000-00021 Twardowski, 1999, Blood access complications and longevity with frequent (daily) hemodialysis and with routine hemodialysis, Semin Dial, 12, 451, 10.1046/j.1525-139X.1999.99078.x Quintaliani, 2000, Survival of vascular access during daily and three times a week hemodialysis, Clin Nephrol, 53, 372 Fagugli, 2001, Short daily hemodialysis, Am J Kidney Dis, 38, 371, 10.1053/ajkd.2001.26103 Lai, 1991, Effect of hemodialysis on protein C, protein S, and antithrombin III levels, Am J Kidney Dis, 17, 38, 10.1016/S0272-6386(12)80248-4 Twardowski, 1977, 6-Year experience with the creation and use of internal arteriovenous fistulae in patients treated with repeated hemodialysis, Pol Arch Med Wewn, 57, 205 Friedman, 2002, Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis, J Am Soc Nephrol, 13, 265, 10.1681/ASN.V131265 Miskulin, 2003, Comorbidity and its change predict survival in incident dialysis patients, Am J Kidney Dis, 41, 149, 10.1053/ajkd.2003.50034 Van Manen, 2003, Adjustment for comorbidity in studies on health status in ESRD patients, J Am Soc Nephrol, 14, 478, 10.1097/01.ASN.0000043902.30577.C9 Miskulin, 2001, Comorbidity assessment using the Index of Coexistent Diseases (ICED) in a multicenter clinical trial, Kidney Int, 60, 1498, 10.1046/j.1523-1755.2001.00954.x Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Lowrie, 2003, Medical Outcomes Study Short Form-36, Am J Kidney Dis, 41, 1286, 10.1016/S0272-6386(03)00361-5